CONMED Corporation (CNMD) is a Medical - Devices company in the Healthcare sector, currently trading at $39.73. It has a SharesGrow Score of 64/100, indicating a above average investment profile with 3 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of CNMD = $153.11 (+285.4% from the current price, the stock appears undervalued). Analyst consensus target is CNMD = $78 (+96.3% upside).
Valuation: CNMD trades at a trailing Price-to-Earnings (P/E) of 24.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.84.
Financials: revenue is $1.4B, +9.7%/yr average growth. Net income is $47M, growing at +73.7%/yr. Net profit margin is 3.4% (thin). Gross margin is 54.6% (+0 pp trend).
Balance sheet: total debt is $835M against $1.0B equity (Debt-to-Equity (D/E) ratio 0.81, moderate). Current ratio is 2.14 (strong liquidity). Debt-to-assets is 35.9%. Total assets: $2.3B.
Analyst outlook: 7 / 21 analysts rate CNMD as buy (33%) — mixed sentiment.
SharesGrow 7-Criteria breakdown: Value 74/100 (Pass), Growth 83/100 (Pass), Past 75/100 (Partial), Health 67/100 (Partial), Moat 70/100 (Pass), Future 52/100 (Partial), Income 30/100 (Fail).
